Daewoong completes EMA application of ‘Nabota’

Published: 2017-07-25 16:30:00
Updated: 2017-07-25 14:08:36

‘Nabota,’ a Daewoong Pharmaceutical’s botulinum toxin, will enter the European market.

EVOLUS, a European partner of Nabota, said it has completed a process of the marketing authorization application(MAA) of DWP-450(Nabota’s development name in the U.S. and Europe) as a forehead wrinkle removal ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.